Impaired gastric acidification negatively affects calcium homeostasis and bone mass
04/01/2010 in PathophysiologyActivation of osteoclasts and their acidification-dependent resorption of bone is thought to maintain proper serum calcium levels. In a recent study [1], the authors show that osteoclast dysfunction alone does not generally affect calcium homeostasis. Indeed, mice deficient in Src, encoding a tyrosine kinase critical for osteoclast activity, show signs of osteopetrosis, but without hypocalcemia or defects in bone mineralization. Mice deficient in a gastrin receptor that affects acid secretion by parietal cells have the expected defects in gastric acidification but also secondary hyperparathyroidism and osteoporosis and modest hypocalcemia. These results suggest that alterations in calcium homeostasis can be driven by defects in gastric acidification, especially given that calcium gluconate supplementation fully rescues the phenotype of the gastrin receptor-mutant mice. Finally, mice deficient in a subunit of the vacuolar proton pump specifically expressed in osteoclasts and parietal cells show hypocalcemia and osteopetrorickets. Although neither Src- nor gastrin receptor-deficient mice have this latter phenotype, the combined deficiency of both genes results in osteopetrorickets.
In conclusion, the authors find that osteopetrosis and osteopetrorickets are distinct phenotypes, depending on the site or sites of defective acidification.
- Schinke T et al. Nat Med. 2009;15:674-681.
|
|
|



Most used keywords
β-catenin age BMD bone bone density bone density test bone formation bone fracture bone loss bone marrow bone remodeling bone resorption bone strength breast cancer calcium cardiovascular cardiovascular disease cell cell bone marrow cholesterol Clinical data diabetes disease epidemiology fracture fracture risk FRAX heart heart disease hip fracture mesenchymal stem cells neuromedin U osteoblast osteoblast differentiation osteoclast osteoporosis osteoprotegerin osterix ovariectomy RANKL residual lifetime risk risk factors sclerotin survival weight loss